What @GregChubak may mean, and correct me if I'm wrong, is that to meet the high admissions targets for H&C in 2023 and 2024 approval rates had to go up. In 2025 and 2026 the planned number of admissions will be reduced. If intake remains the same one of three things will need to happen. Either the approval rate remains the same, in which case if IRCC wants to stick with their admissions plan processing times will have to increase. Or if they want to stick with their admissions plan without impacting processing times approval rates will have to decrease. Or they will blow through their admissions targets.
What @GregChubak may mean, and correct me if I'm wrong, is that to meet the high admissions targets for H&C in 2023 and 2024 approval rates had to go up. In 2025 and 2026 the planned number of admissions will be reduced. If intake remains the same one of three things will need to happen. Either the approval rate remains the same, in which case if IRCC wants to stick with their admissions plan processing times will have to increase. Or if they want to stick with their admissions plan without impacting processing times approval rates will have to decrease. Or they will blow through their admissions targets.
@smeurrens @GregChubak Interesting. I wonder if IRCC leveraged the H&C case type in GCMS for some of their public policies in order to meet levels. So, they're not H&C as typically defined.
@smeurrens @GregChubak You have to consider stage 2 inventory from previous years